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IT was shown by Levi et al. (1959) that antiserum to Ehrlich's ascites tumour,
produced in rabbits which had been pre-treated during the neonatal period with
injections of normal C3H mouse tissue homogenate, was more effective in protect-
ing mice against this tumour than was antiserum produced in normal control
rabbits. Working with human myelogenous leukaemia Garb, Stein and Sims
(1962) demonstrated that precipitating antibodies against leukaemia cells could
be produced inrabbitswhich had been similarlypre-treated withnormalleucocytes.
The following experiment was designed to show whether anti-L-5178 mouse
lymphoma serum produced in rabbits pre-treated with normal DBA/2 mouse
tissue, would have a cytotoxic effect against this mouse tumour in vitro and in
addition show the properties of neutralization and protection in mice inoculated
with this tumour.
MATERIALS AND METHODS
Mice.-The mouse strain used was the closely inbred DBA 2, which was the
strain from which L-5178 tumour originated. These mice were obtained from the
Laboratory Animals Centre, Carshalton, and maintained over the past year under
their subcultivation scheme. This consisted essentially of mating mice only
within their own generation and not keeping the colony for experimental use for
more than 3 generations.
Rabbits. Newborn rabbits were divided into 3 groups designated as test,
control and normal. Test rabbits were pre-treated in the neonatal stage with
normal mouse antigen and later immunized with mouse tumour antigen. Control
rabbits received no pre-treatment in the neonatal stage but were later immunized
with mouse tumour antigen. Normal rabbits received neither pre-treatment nor
immunization and were used solely as a source of normal rabbit serum.
Mouse lymphoma L-5178.-This tumour is a lymphocytic neoplasm originating
in 1952 in the thymus of a DBA/2 mouse treated with methylcholanthrene at
the National Cancer Institute (Carcinogenesis Section) Bethesda, Maryland,
U.S.A. (Law, L. W., 1961, personal communication). This cell line was obtained
by us from the Chester Beatty Institute of Cancer Research in 1961 and has been
maintained in our inbred strain of DBA/2 mice by weekly passage as an ascites
cell, by intraperitoneal injections of 0-2 ml. of a 1 in 10 dilution of ascitic fluid in
normal saline.
Normal mouse antigen.-Four month old DBA/2 mice were killed and the
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washed in Hanks buffered salt solution containing antibiotics at the following
concentrations
Penicillin 500 units/ml., streptomycin 250 jig./ml., neomycin 125 jag./ml.,
nystatin 62-5 units/ml. Homogenization in an equal volume of the above
solution was carried out in an M.S.E. tissue blender. The homogenate was
then further diluted to give a 20 per cent suspension and this was treated with
No. 11 Ballotini beads on a Mickle shaker to effect fine disintegration of the
tissues. The suspension was finally strained through a copper sieve of average
pore size 152 It to ensure that the material could be inoculated through a
small bore needle. These operations were performed at 40 C. The homogenate
was tested for bacteriological sterility and then stored at -20° C.
Mouse lymphoma L-5178 antigen.-Nineteen 6 month old DBA/2 mice were
each inoculated with 0-2 ml. of a 1 in 10 dilution in normal saline of ascitic fluid
from a tumour-bearing mouse. On the 8th day the mice were killed, the solid
tumour removed from the peritoneal cavity and washed three times in buffered
salt solution containing antibiotics as above. The tumour was then homogenized
and subsequent treatment was the same as for tissues used for preparation of the
normal mouse antigen.
Adjuvant.-This consisted of a modification of Freund's formula (Leskowitz
and Waksman, 1960): Bayol, F. 8-5 volumes, Arlacel A. 1-5, volumes, freeze-
dried heat killed tubercle bacilli, 20 mg. Equal volumes of this mixture and
the tumour antigen were homogenized in the blender and used for immunization.
Rabbit antisera.-Blood was obtained from test and control rabbits preceding
immunization and on the 14th and 28th day after the last immunizing injection.
Sera were stored at -200 C.
Pre-treatment of test rabbits.-Within 12 hours of birth the course of inocula-
tions was started. This consisted of 1 ml. of normal mouse antigen intraperi-
toneally on alternate days for 21 days. Certain precautions were found necessary
in handling the litters. The hands were smeared with dilute oil of aniseed and
the mother was then removed to another room so that she could not observe the
inoculation of heryoung. A total of11 rabbits out of 23 survived this treatment.
Immunization of test and control rabbits.-At 3 months of age the 11 pre-
treated test rabbits together with 15 untreated controls received weekly intra-
peritoneal inoculations of1 ml. of tumour antigen for 4 weeks. At the end of the
2nd and 4th weeks, additional antigen (0.4 ml.) together with modified Freund's
adjuvant was given intradermally at 4 different sites.
Sk-in tests.-A small area on each flank was shaved. 0-2 ml. of normal mouse
antigen was injected intradermally on one side and 0-2 ml. of tumour antigen on
the other. The rabbits were challenged at the same sites with the same antigens
10 days later in order to elicit an Arthus reaction. The extent of the reaction
was measured in arbitrary units obtained by multiplying the diameter of the
indurated area by its thickness. This was found to be maximum at 6 hours.
Ouchterlony technique.-5 ml. of 1 per cent Jonagar No. 2 (Oxoid) in distilled
water was poured into 2-5 inch petri dishes. When the agar had set, holes were
cut using a standard 6 hole cutter (Shandon Scientific Co.) with an additional centre
cup. The reagents to be tested were pipetted into the cups and left at room
temperature until lines appeared. The plates were then stored at 40 C. The
pre-immunization samples of blood, and the 14th and 28th day post-immunization
samples were all tested.
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Tumour neutralization test (IN VITRO).-Tumour cell suspension containing
500,000 cells,/ml. in normal saline were incubated at 370 C. for 3 hours with equal
volumes of pooled sera from test, control and normal rabbits. Mice, in groups of
four, were then given intraperitoneal inoculations of 0-2 ml. of this mixture so
that each mouse received 50,000 cells. Survival times of these groups were
compared.
Tumour neutralization tests (IN VIvO). A tumour cell suspension consisting
of 50,000 cells on 0*2 ml. normal saline was given intraperitoneally to each of 30
mice. The mice were divided into 3 groups and treated with 0 4 ml. of 28th day
post-immunization sera from the test, control and normal rabbits. The time
interval between inoculation of tumour cells and commencement of serum treat-
ment was varied, intervals of 15 minutes, 18 hours and 36 hours being selected.
Once started the injections of sera were repeated every 48 hours until the mice
receiving normal rabbit serum had died. Survival times of these groups were
compared.
Mouse protection tests.-Ten mice were treated with 0-4 ml. of sera from con-
trol rabbits on alternate days for 8 days. Six hours after the last injection 500,000
cells in 0*2 ml. normal saline were given intraperitoneally to each mouse.
RESULTS
Skin tests.-Table I shows the reactions measured in arbitrary units of test,
control and normal rabbits to normal and tumour antigens.
TABLE I.-Skin Tests
Reaction to Reaction to
normal mouse mouse tumour
Rabbits antigen (units) antigen (units)
Test . 39 . 26
Control . 120 . 158
Normal Negative . Negative
Ouchterlony tests.-None of the immune sera from 11 test rabbits showed any
)recipitin lines to either normal or tumour antigen. All 15 immune sera from the
control rabbits showed two or three lines against both antigens.
None of the pre-immunization sera from test or control rabbits showed any
precipitin lines against either antigen.
Both normal mouse sera and sera from tumour-bearing mice gave a single
diffuse broad band against the test and control rabbit sera. This line was readily
(listinguishable from the sharp, narrow lines produced by the normal and tumour-
ous mouse antigen against the immune rabbit sera and was probably due to
mouse serum proteins.
The general pattern of precipitin lines produced by normal and tumourous
mouse tissue against the control rabbit sera indicated that the antigens concerned
were similar.
Tumour neutralization test (IN VITRO).-Table II shows the survival times of
50 per cent of mice inoculated with tumour cells which had been previously
incubated with test, control and normal rabbit sera. Pre-immunization sera
from test and control rabbits showed no effect on survival time when compared
with normal rabbit sera.
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TABLE II.-Neutralization Tests (IN VITRO)
Rabbit sera
Test, 28th day immune sera
Control 28th day immune sera
Normal sera
50 per cent
survival time of mice
No deaths from tumour
No deaths from tumour
14 days
Tumour neutralization tests (IN vivo).-Table III shows the survival times
of 50 per cent of tumour-bearing mice which had been inoculated at various
times with serum from test, control and normal rabbits. Pre-immunization sera
from test and control rabbits showed no effect on survival time as compared with
normal rabbit sera.
TABLE III.-Neutralization Tests (IN VIVO)
Rabbit sera
used for treatment
Test, 28th dav immune sora
Control ,, .. .
Normal sera
Test, 28th day immune sera
Control ,,
Normal sera
Test, 14th day immune sera
Control ,. . . ..
Normal sera
Time interval between
initiation of treatment
and inoculation of tumour
15 minutes
18 hours
36 hours
,.1 ..1
* One mouse survived for 3 months with no evidence of tumour at necropsy.
t Four mice alive after 10 months, with no evidence of tumour growth.
50 per cent
survival
time of mice
(days)
23*
30t
15
16
17
13
14
13
13
Mouse protection test.-Table IV shows survival times of 50 per cent mice
treated with sera from control and normal rabbits prior to inoculation oftumour.
TABLE IV.-Mouse Protection Test
Rabbit sera
Control, 28th day immune scra
Normal sera
50 per cent
survival time of mice
(days)
16
12
Toxic effects of sera.-The sera from the control rabbits appeared to produce
signs of anaphylactic shock in the mice. This was manifested by shivering,
weakness and convulsions lasting for about 30 minutes after the inoculations.
In preliminary experiments several mice died within a few hours ofadministration
ofthe 14th day post-immunization sera. Mice inoculated with sera from the test
rabbits exhibited these signs to a noticeably lesser degree, recovering completely
in 10-15 minutes; mice inoculated with normal rabbit sera were unaffected.
Effect of sera on growth of tumour.-It was found at post-mortem examination
that a plaque of tumour was present at the point of entry of the needle into the
peritoneal cavity, in about 80 per cent of the mice inoculated with normal rabbit
sera. Infiltrations ofthis sort were not seen in mice treated with sera from either
test or control rabbits.
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DISCUSSION
The purpose of this study was two-fold. In the first place our object was to
see whether rabbits could be made wholly or partially tolerant to normal DBA/2
mouse tissue antigens and secondly whether antisera produced in these tolerant
rabbits against L-5178 tumour would be as cytotoxic to the tumour as antisera
prepared in untreated controls.
The in vivo neutralization test showed that, when treatment was started within
15 minutes of the tumour cell inoculation, survival time was prolonged by both
control sera and test sera, though less so by the latter. When the interval between
initiation of treatment and inoculation of tumour cells was increased to 18 hours,
prolongation of survival time was decreased and at 36 hours neither test or control
sera produced any significant prolongation of survival time.
Thus it appeared that the test sera, in spite of having been produced in rabbits
tolerant or partly tolerant to normal mouse tissue antigens, were almost as potent
neutralizing agents as the sera produced in untreated controls.
The in vitro neutralization test showed that immune sera from both test and
control rabbits had a strong cytotoxic effect on the mouse tumour cells, whereas
normal rabbit sera and sera from test and control rabbits before immunization had
no cytotoxic effect. The damage to the cells therefore appeared to be caused by
circulating antibody, rather than by complement or some other cytotoxic sub-
stance present in these sera.
These effects might have been due partly to the action of antibody against
normal tissue antigens present in the tumour and partly against a tumour antigen
or other antigen not present in normal DBA/2 mouse tissue. The fact that control
sera tended to prolong the survival time of the mice to a greater extent than did
the test sera was in favour of the former explanation. On the other hand, the
fact that the test sera, which were apparently devoid of precipitating antibodies
against either normal or tumour antigens were nevertheless capable of pro-
longing survival time is an indication that it might contain antibody against an
antigen not present in normal DBA/2 tissue. This antigen might be a tumour
antigen, of the type demonstrated on the EL4 leukosis by Gorer and Amos (1956)
or a mutant normal antigen of the type which Klein (1959) has shown might
develop as a result of continuous transplantation over a long period. These
antigens however, were not demonstrated in the Ouchterlony plate tests.
There appeared to be quite a significant difference in the skin reactions to
normal mouse and tumour antigen in the test and control rabbits, the controls
responding approximately 4 times as strongly as the test rabbits. This was taken
to indicate tolerance to normal tissue antigens and serum proteins, induced by
pre-treatment of the test rabbits. Since the reactions were of Arthus type it was
considered that the test rabbits have a diminished ability to produce circulating
antibody in response to these antigens.
The skin reaction by both test and control rabbits against tumour tissue was
less than that against normal tissue. This might be an indication of some loss
of antigenicity by the tumour tissue. Lack of organ specific antigens has been
demonstrated in the rat liver, hamster kidney and human skin tumours by Nairn
et al. (1960).
The results of the Ouchterlony tests showed an inability to produce precipita-
ting antibody on the part of the test rabbits. It was unexpected to find that no
precipitin lines at all appeared between the normal or tumour antigen and the test
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sera. This was contrary to our predictions since recently Garb et al. (1962) were
able to demonstrate a precipitin line between human myelogenous leukaemia
homogenate and the sera of rabbits made tolerant to normal leucocytes. Our
Ouchterlony test showed that tolerance has been acquired to a mixture of DBA 2
normal mouse antigens. This property of rabbits to acquire tolerance to multiple
antigens has also been demonstrated by Garb and Stein (1962).
Thus as far as precipitin producing antigens were concerned the L-5178 tumour
did not appear to differ from the normal DBA/2 mouse tissue.
We substantiated to some extent the opinion of Levi et al. (1959) that sera
from control rabbits proved very much more toxic to mice than that from test
animals. These workers however, were using a different tumour, Ehrlich's
ascites, and a different strain of mice, C3H. Antigenic differences between the
tumour and the C3H mice might account for the fact that antiserum produced in
their control rabbits against the Ebrlich's ascites tumour proved lethal on inoc-
ulation into tumour bearing C3H mice.
These results led us to expect that antisera against tumours produced by
this method in our test or tolerant animals might be, in general, less damaging
to normal host tissue than that produced in our control or non-tolerant animals.
Immune sera produced in tolerant rabbits might be slightly less potent but their
comparative lack of toxicity and lower content ofprecipitating antibodies against
normal tissues, might enable them to be greatly concentrated and eventually
used for the diagnosis and therapy of human tumours.
SUMMARY
1. A method of producing tolerance in rabbits to normal mouse tissue is
described and tolerance demonstrated by means of agar gel precipitin tests and
skin tests.
2. The production of antisera against the L-5178 mouse lymphoma in these
tolerant rabbits and in non-tolerant controls is described.
3. Neutralization tests show that antisera produced in test (tolerant) and
control (non-tolerant) rabbits are cytotoxic to L-5178 cells in vitro. These
antisera will also confer passive immunity and protection by prolonging the
survival time of mice inoculated with this tumour. The antisera produced in
non-tolerant controls, however, are more toxic.
4. The significance of these findings is discussed and a possible application to
the diagnosis and therapy of human tumours is suggested.
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